Ad
related to: ai in pharmaceutical industry
Search results
AI will not magically solve business challenges. It’s time to re-shape the narrative
Euronews via Yahoo News· 2 days agoThe right AI solutions are out there for businesses. It’s just about identifying them and...
OCT Europe: Unless everyone is benefiting, what is the point?
Pharmaceutical Technology via Yahoo Finance· 11 hours agoThere were also questions asked about the lack of tech development in EMA guidance, with Yates...
Cathie Wood Is Buying This Under-the-Radar AI Stock
Motley Fool via Yahoo Finance· 3 days agoRecursion developed an AI-powered operating system (OS) that tests how various clinical compounds might interact...the probability that they will make it...
Recursion Pharmaceuticals CEO explains how AI could make drug development faster and less costly
CNBC· 5 days agoIn a Friday interview with CNBC's Jim Cramer, Recursion Pharmaceuticals CEO Chris Gibson discussed...
Ecolab Life Sciences to unveil bioquell qube and more at BIO 2024
BioPharma-Reporter· 9 hours agoBPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we...
Idea Fund of La Crosse raises $31.5 million for another venture capital fund in Upper Midwest
Milwaukee Journal Sentinel via Yahoo Finance· 12 hours agoThe 3-year-old company has clients in the manufacturing of food and beverage products, consumer...
...Cannabis Post-Rescheduling? Data Analytics Expert Weighs In - Corbus Pharmaceuticals...
Benzinga· 1 day agoKey states driving this surge include New York, New Jersey and potentially Florida and Ohio, Bingham...
Immix Biopharma CEO buys $9.7k in company stock By Investing.com
Investing.com· 20 hours agoImmix Biopharma Inc.'s CEO and Chairman, Ilya M. Rachman, has recently increased his investment in...
Novartis to showcase next-gen manufacturing solutions at BIO 2024
BioPharma-Reporter· 9 hours agoAt BIO 2024, Novartis Contract Manufacturing will actively demonstrate its commitment to supporting...
Bayer maintains shares price target, Hold rating on near-term headwinds By Investing.com
Investing.com· 3 hours agoThe firm's decision reflects an anticipation of near-term challenges, despite some areas of growth...
